PMP2 and Guillain-Barre syndrome: The immunomodulatory effects of DMF in the animal model of acute and chronic autoimmune, demyelinating diseases of the peripheral nervous system [Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP)] the experimental autoimmune neuritis (EAN) have been previously investigated from our group after neuritis induction with myelin protein P2 emulsified in complete Freund's adjuvant (CFA) (14, 15).